View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Leading biomarker services companies in clinical research

The role of biomarkers in drug discovery and development is increasing incessantly in several therapeutic areas such as oncology, cardiology, immunology, metabolic and neuroscience.

The identification of biomarkers associated with a patient’s responsiveness to investigational drugs can help in achieving significant efficacy with minimum adverse events in clinical trials on the targeted patient population.

Biomarker identification and adoption are especially valuable in rare diseases and precision medicine development, which requires a wide array of services throughout the entire process of clinical research such as DNA sequencing, gene expression profiling, large molecule bioanalysis, cell separation technology and more. It also requires innovative technologies and state-of-the-art platforms to support both pre-clinical and clinical biomarker studies.

Finding the top biomarker services companies in clinical research

Clinical Trials Arena has listed some of the leading biomarker services companies in clinical research based on its intel, insights, and decades-long experience in the sector. The list includes companies that provide various products and services, including:

  • Biomarker detection and biomarker R&D services for membrane proteins and antibodies
  • Discovery, assay development and testing of biomarkers
  • Clinical biomarker services, and clinical kitting services
  • Biomarker plan and biomarker validation services
  • Screening biomarkers, biomarker testing, and custom assay development
  • Biomarker analysis services
  • Biomarker platform technologies such as immune monitoring, flow cytometry, bioanalytical testing, immunophenotyping, and cytokine analysis
  • Assessments of nucleic acid therapeutics
  • Formulation and product chemistry
  • Anatomic pathology
  • In-vitro drug development, histoculture drug response assays, methylation studies, and high throughput data analysis
  • Genomic and tissue biomarker services, and cell services, and
  • Transfer of proprietary assays

The information contained within the download document is intended for clinical research coordinators, research associates, clinical biomarker specialists, clinical scientists, clinical science directors, clinical biomarker development scientists, clinical trial associates, project specialists, data analysts, biostatisticians, clinical data associates, product managers, and any other individual involved in biomarker services in clinical research.

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.

Importance of biomarker services for pharma

The successful identification of a suitable biomarker is an important factor for drug development. It helps a pharmaceutical company in the detection and classification of pathological processes and monitoring the course of therapy.

The biomarker-driven approach for patient selection strategies and the development of precision medicines has the potential to increase the success rate of the drug development process, reduce expenses, and ultimately improve patient health outcomes.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena